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Mann-Whitney t-test. Correlations between cytokines, proteases, and cell-
lineage markers were detected using Spearman’s correlation test.
Results: SM Il-15 mRNA and SF protein levels were detectable in all
early OA patients (18 SM and 11 SF), and in most end-stage patients as
well (11/13 SM and 9/10 SF); furthermore protein levels were elevated
in the early knee OA patients when compared to end-stage (p = 0.0004).
In contrast, SM Il-21 mRNA levels were detectable in 11/18 early OA
patients and in all end-stage patients, while SF protein levels were
measurable in 7/10 end-stage and 5/9 early OA patients. Il-21 mRNA and
protein levels did not differ in the two patient groups. In early OA patients,
Il-15 transcript levels within the tissue were associated with CD8 transcript
levels (r = 0.508, p = 0.04), and Il-21 mRNA levels correlated with CD19
(r = 0.746, p = 0.0009) and CD56 (r = 0.742, p = 0.0015) expression, con-
sistent with the known effects of these cytokines on speciﬁc lymphocyte
subsets. Il-15 transcript levels were associated with both Il-21 mRNA
(r = 0.445, ns trend p=0.08) and protein levels (r = 0.783, p = 0.017), sug-
gesting coordinate regulation of these two cytokines. Finally, increasing
SF Il-15 was positively associated with both total (r = 0.582, p = 0.023)
and active (r = 0.576, p = 0.025) SF MMP-1 concentration.
Conclusions: The common-gamma chain cytokines, Il-15 and Il-21, are
produced within the joint in the majority of patients with end-stage knee
OA, as well as in patients with degenerative meniscal tears and signs
of early cartilage degeneration. Furthermore, Il-15 levels are elevated
in early knee OA, implicating innate immune system activation early in
the disease process. The association of Il-15 with MMP-1 implicates this
cytokine in extracellular matrix remodeling in OA.
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Purpose: Hyaluronidase (Hyal) and hyaluronic acid synthase (HAS) were
cloned in human recently. HAS-1 and HAS-2 synthesize high molecular
weight (2×106 Da) hyaluronic acid (HA), while HAS-3 synthesizes low
molecular weight one (2×105 Da). It has been obscure why the molec-
ular weight of HA in synovial ﬂuid (SF) decreases in the patients with
rheumatoid arthritis (RA). In order to study the relationship between
the expression patterns of Hyals, HASs, Hyal activity and HA molecular
weight in SF, we examined the expression of these enzymes in the
articular tissue of patients with RA.
Methods: Synovial tissues/ﬂuids were obtained from 58 patients with
RA at various stage of inﬂammation, 27 patients with osteoarthritis and
6 with trauma. We studied Hyals (Hyal-1, -2, -3) and HASs (HAS-1,
-2, -3) expression by using mRNA in situ hybridization analysis and
immunohistochemistry. In addition, we investigated Hyal activity in SF
samples by HA substrate gel enzyme zymography. Then we examined
HA molecular weight in SF by HPLC.
Hyaluronidase activity and molecular weight of HA in SF.
Results: Hyals were detected in synoviocytes. The number of positive
cells of Hyals was higher in RA active stage than in non-inﬂamed control
patients. Utilizing Hyal enzyme zymography, the enzyme activity of Hyal
in synovial ﬂuid was higher in the active stage of RA than in the ﬁbrotic
one. There was negative correlation between Hyal activity and molecular
weight of HA in SF (r = −0.55, p< 0.005) (Fig). The enzyme activity of Hyal
in SF was positively correlated with the number of positive cells of Hyals
mRNA in synovial tissues. HAS-1, -2 were detected in synoviocytes. On
the other hand, HAS-3 was detected in synoviocytes and inﬂammatory
cells. The number of positive cells of HAS-1 and HAS-2 was lower
in RA advanced stage although that of HAS-3 positive cells reached
maximum level in the active inﬂammatory stage. Moreover, the number
of HAS-3 positive cells was negatively correlated with the HA molecular
weight in synovial ﬂuid (r = −0.51, p< 0.005) and positively correlated
with histologically deﬁned local inﬂammatory activity in RA (r = 0.563,
p< 0.005).
Conclusions: The results suggest that HA may be actively synthesized
by HAS-1 or HAS-2 in early stage of RA and become to smaller size
by HAS-3 products and degeneration by Hyals in inﬂammatory stage of
RA. The number and distribution of Hyals and HASs can be affected by
synovial inﬂammation.
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Purpose: There are many in vitro systems for studying cartilage degen-
eration, but most do not model interactions between the various cell types
in a joint. We developed an in vitro model of cartilage degradation using
cells that are representative of those found in osteoarthritic joints. Our
goal was to generate a compositional proﬁle similar to that found in OA
synovial ﬂuid (as distinct from that in inﬂammatory conditions, such as
rheumatoid arthritis) that would lead to cartilage degeneration.
Methods: Synovial ﬁbroblasts (Type B cells), isolated from a 68-year-
old normal donor, were cultured overnight at 2.5×104/cm2 in 24-well cell
culture inserts in medium containing DMEM with 10% FBS and 50 ug/ml
Gentamicin. The next day, premonocytic U937 cells, representing synovial
Type A cells, were added to the insert at 1.0×105/cm2. The two cell types
were cultured together for 3 days, promoting differentiation of the U937
cells into monocytes. After 3 days, medium was changed to be serum-free
and 6mm full-thickness cartilage discs isolated from 6-month-old calves
were added to the wells containing the cell-laden inserts. To stimulate
the system with potential mediators of OA, cultures were treated with the
N-terminal 30 kDa ﬁbronectin fragment (Fn-f, 0.8 mM) or urokinase-type
plasminogen activator (uPa, 15 nM). Il-1b treatment (5 ng/mL) was used
as a positive control. To study the speciﬁc effects of Il-1 on stimulated co-
cultures, some samples were preincubated with 1.4 nM Il-1ra for 4 hours
before stimulation. After 7 days, medium was assessed for sGAG content
(DMMB), and for Il-1b, Il-1ra, Il-10, Il-6, Il-8, RANTES, TNFa and MMP-1,
-3, and -13 (Luminex xMAP). GAG was also determined in cartilage discs
(DMMB, and Safranin O histology).
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Results: Coculture of the U937 cells with synovial ﬁbroblasts resulted in
differentiation of U937 into monocytes, as evidenced by FACS indicating
that they were CD14+. Over 7 days, the cytokine and chemokine levels
in the media of these cocultured cells with cartilage explants approached
levels similar to those reported for OA synovial ﬂuid, including low levels
of Il-1b and TNFa. GAG release was observed in co-cultures stimulated
with Il-1b, uPA, or Fn-f, with the most severe effects in the Il-1b-treated
group (Figure). However, the concentration of Il-1b used in the control
samples, typical of concentrations used by others for release of GAGs
from cartilage disks in vitro, is far greater than the concentration reported
in OA synovial ﬂuid. Pretreatment with Il-1ra was able to inhibit the loss of
GAG from the cartilage in the Il-1b stimulated samples, but did not block
Fn-f-stimulated GAG release in the co-culture system, and had a small
effect on uPA stimulated GAG release.
Conclusions: An in vitro model of cartilage degradation has been devel-
oped utilizing a co-culture of human synovial ﬁbroblasts with differentiated
U937 cells, in the presence of bovine cartilage explants. The interaction
of these cell types generated a cytokine proﬁle similar to OA synovial
ﬂuid, and stimulation of this system with uPA or Fn-f led to cartilage
degradation (GAG loss). Our ongoing work will continue to explore the
roles of various cytokines and the molecular mechanisms through which
they inﬂuence cartilage degeneration in this in vitro joint model system,
and their potential relation to OA disease progression.
Matrix Biochemistry
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Purpose: To conﬁrm that previously reported changes in collagen and
GAG content from knee OA cartialge also occur in hip OA and that
these changes are different from those in reference cartilages. We also
examined the relationships between total collagen, % denatured collagen
and GAG content and with age.
Methods: 18 OA (aged 45 to 81, 11 women) and 26 reference (aged 55
to 99 years, 20 women) femoral heads were collected at hip replacement
surgery, due to OA or femoral neck fracture. OA cartilages were taken
from sites where it was possible to sample full-depth cartilages whereas
reference cartilages were taken from the superior most loaded areas.
Cartilages from the same site were examined for routine histology and
immunohistochemistry. Each sample was divided into two parts that were
either, digested with 1mg/ml a-Chymotrypsin in 50mM tris containing
the proteinase inhibitors to extract denatured collagen, or with papain
at 60C for 18 h (1−2ml of papain/10mg wet weight tissue) in 0.1M tris-
HCl, pH 7.2, containing 0.01M disodium EDTA and 0.005 cysteine-HCl
to enable GAG analysis. The Chymotrypsin supernatants (containing
cleaved collagen) and residues (containing intact collagen) were hydrol-
ysed in 12N and 6N HCl, respectively, at 110ºC overnight and then
dried. Subsequently the samples were dissolved in 500 ml of distilled
water and clariﬁed using an equal amount of charcoal and AG-1 X8
anoin exchange resin. The amount of hydroxyproline (Hyp. mg/mg wet
weight) was measured colorimetrically at 550 nm. The values from the
assay were compared to those from a standard curve prepared with
L-4-Hydroxyproline. Amounts of hydroxyproline were expressed either
as total collagen or % degradation. The papain-digested samples were
assayed for GAG by a commercially available kit using dye-precipitation
of sulphated GAGs with Alcian blue (www.wieslab.com).
Results: The reference group was older than the OA group (p< 0.001).
Collagen content was 23% lower in OA than reference cartilage
(p = 0.002). % Denatured collagen was 2.5 times higher in OA than that
of reference cartilages (p = 0.001).
% Denaturation was inversely related to collagen content in OA cartilage
(r = −0.78, p = 0.000) but not in the reference cartilage (p = 0.5).
GAG content was similar in reference and OA cartilages. GAG content
was inversely related to % denatured collagen in OA and reference sam-
ples; lower GAG was present in samples with more denatured collagen.
Amounts of collagen and GAG and % denatured collagen were not
related to patients’ age. The Mankin and immunohistochemistry grades,
higher in OA than in reference samples (p< 0.001), were not related to
% denaturation, collagen or GAG content.
Conclusions: The present study provides new perspectives of the re-
lationships between the two main molecules, collagen and aggrecan, in
OA and reference articular cartilage. Similar collagen damage in hip OA
cartilage as previously shown in knee OA cartilage suggest similar OA
degradative mechanisms of collagen in different joints. With respect to
age, our study shows similarities between OA and reference cartilage.
The lack of relationships between molecule contents and age may sug-
gest that subjects age is not related to disease activity or suseptibility.
Rather we believe that exposure time to a risk factor is of importance.
The increased degree of denatured collagen and the inverse relationship
between % denatured collagen and collagen content in OA compared to
reference cartilage indicates mechanisms of progressiveness in disease
that are not activated in normal ageing. Therapeutic interventions in
progressive hip and knee OA may include means to control cartilage
collagen content using inhibitors that decrease collagen degradation as
well as treatments that increase cartilage GAG content in order to improve
cartilage quality.
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Purpose: Matrix Metalloproteases (MMP) and aggrecanases are essen-
tial players in cartilage degradation. However, the signaling pathways
involved that results in MMP and aggrecanase synthesis and activation
are not well understood. We investigated whether the p38 MAPK was
involved in processes leading to collagen type II degradation in catabolic
stimulated articular cartilage.
Methods: Bovine articular cartilage explants were isolated from stiﬂe
joints from slaughtered cows 1.5−2 years of age. The explants were cul-
tured serum-free in Dulbecco’s Modiﬁed Eagle’s Medium in the presence
of 10 ng/ml Oncostatin M (OSM) and 20 ng/ml Tumor Necrosis Factor-a
(TNF) with or without the speciﬁc inhibitors of p38 MAPK SB-203580
or SB-202190, respectively, in doses of 0.1, 1 or 10 mM for 21 days
with change of conditioned medium every 2−3 day. Cartilage explants
cultured in medium alone and metabolically inactivated explants were
used as control. Cell viability was followed by the Alamar blue colorimetric
assay. Total cartilage proteoglycans were isolated from the cultured
cartilage explants after the culture period by 4M GuHCl extraction for
48 h. Collagen type II degradation was analyzed by the CTX-II assay
and by hydroxyproline quantiﬁcation. MMP activity was assessed in the
conditioned medium using the Mca-Pro-Leu-Gly-Leu-Dap(Dnp)-Ala-Arg-
NH2 MMP substrate with a quencher and a highly ﬂuorescent end, and
the cleavage was followed by quantiﬁcation of the ﬂuorescence.
Results: Stimulation of cartilage degradation by OSM+TNF resulted in
a 100-fold induction of CTX-II release (p< 0.01), compared to vehicle
treated and metabolic inactive controls. The total levels of proteoglycan
in the explants decreased by 50%, p< 0.0001 in the OSM + TNF treated
cartilage compared to vehicle control, but the p38 inhibitor SB-203580
was able to retain the levels of proteoglycans by 35%, p< 0.01, compared
to vehicle control. Exposure of the articular cartilage explants to OSM +
TNF, and the speciﬁc p38 MAPK inhibitors SB-203580 or SB-202190,
resulted in a dose-dependent complete abrogation of MMP mediated
collagen type II degradation (CTX-II). This was in alignment to the quantiﬁ-
cation of hydroxyproline levels, (p< 0.01). In support, p38 MAPK inhibition
resulted in a dose-dependent abrogation of MMP activity measured by
the ﬂuorescence assay. In addition, no toxic effect was observed on cell
viability.
Conclusions: We found that the inhibition of p38 MAPK abrogated
proteolytic cartilage degradation by blocking MMP synthesis and activity.
These results suggest that pathways resulting in less p38 signaling may
be potential options for indirect modulation of MMP expression and
activity. This may be important for the discovery of new potential OA
treatments.
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Purpose: Early diagnosis of osteoarthritis is important, although the
diagnostic method is not fully established yet. It is well known that
